PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 180 filers reported holding PTC THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $120 | -31.4% | 5,400 | +24.5% | 0.00% | – |
| Q2 2023 | $175 | +177.8% | 4,337 | +228.6% | 0.00% | – |
| Q1 2023 | $63 | -33.0% | 1,320 | -46.7% | 0.00% | – |
| Q4 2022 | $94 | -99.8% | 2,478 | +115.1% | 0.00% | – |
| Q3 2022 | $57,000 | -93.9% | 1,152 | -95.4% | 0.00% | -100.0% |
| Q1 2022 | $939,000 | +1119.5% | 25,192 | +1197.2% | 0.00% | – |
| Q4 2021 | $77,000 | +600.0% | 1,942 | +588.7% | 0.00% | – |
| Q2 2021 | $11,000 | -92.8% | 282 | -91.2% | 0.00% | – |
| Q1 2021 | $152,000 | -75.2% | 3,213 | -68.0% | 0.00% | -100.0% |
| Q4 2020 | $612,000 | +774.3% | 10,034 | +535.1% | 0.00% | – |
| Q1 2020 | $70,000 | +536.4% | 1,580 | +356.6% | 0.00% | – |
| Q3 2019 | $11,000 | -96.3% | 346 | -96.3% | 0.00% | -100.0% |
| Q4 2015 | $300,000 | -27.5% | 9,275 | -40.2% | 0.00% | 0.0% |
| Q3 2015 | $414,000 | – | 15,509 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,750,000 | $84,053,000 | 7.32% |
| RTW INVESTMENTS, LP | 3,832,480 | $184,074,000 | 6.94% |
| Burrage Capital Management LLC | 195,725 | $9,401,000 | 6.30% |
| Asymmetry Capital Management, L.P. | 55,408 | $2,661,000 | 4.77% |
| SECTORAL ASSET MANAGEMENT INC | 328,738 | $15,789,000 | 2.36% |
| ARMISTICE CAPITAL, LLC | 758,000 | $36,407,000 | 2.10% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 114,000 | $5,470,000 | 1.97% |
| Opaleye Management Inc. | 191,000 | $9,174,000 | 1.80% |
| Sofinnova Investments, Inc. | 517,092 | $24,836,000 | 1.79% |
| Chubb Ltd | 8,180 | $393,000 | 1.68% |